The interaction of DNA-targeted 9-aminoacridine-4-carboxamide platinum complexes with DNA in intact human cells

Mark D Temple1, Patsy Recabarren, W David McFadyen

  • 1School of Biochemistry and Molecular Genetics, University of New South Wales, Sydney, NSW 2052, Australia.

Insights

Novel platinum (Pt) complexes targeting DNA show altered sequence specificity compared to cisplatin. These DNA-targeted Pt complexes also damage DNA approximately four times faster than cisplatin in human cells.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Genetics

Background:

  • Cisplatin is a widely used platinum-based chemotherapy drug.
  • Understanding the DNA damage mechanisms of platinum analogues is crucial for developing more effective cancer therapies.
  • Novel platinum complexes are being investigated to overcome cisplatin resistance and reduce side effects.

Purpose of the Study:

  • To investigate the sequence specificity and kinetics of DNA adduct formation for novel 9-aminoacridine-4-carboxamide Pt complexes in HeLa cells.
  • To compare the DNA damage patterns and reaction rates of these novel complexes with cisplatin.
  • To determine if altered DNA sequence specificity can be achieved with cisplatin analogues in human cells.

Main Methods:

  • Utilized Taq DNA polymerase and a linear amplification/polymerase stop assay to analyze DNA damage sites.
  • Employed primer extension inhibition by platinum-DNA adducts to map lesion locations on DNA sequencing gels.
  • Targeted the repetitive alphoid DNA sequence in intact HeLa cells for damage analysis.

Main Results:

  • The 9-aminoacridine-4-carboxamide Pt complexes demonstrated a distinct sequence specificity compared to cisplatin, with a reduced preference for guanine runs.
  • These novel complexes showed an enhanced preference for GA dinucleotides.
  • DNA-targeted Pt complexes exhibited significantly faster DNA damage kinetics, reacting approximately four times more rapidly than cisplatin.

Conclusions:

  • This study presents the first evidence of altered DNA sequence specificity for a cisplatin analogue in human cells.
  • The novel 9-aminoacridine-4-carboxamide Pt complexes offer a promising new class of platinum-based anticancer agents with potentially improved therapeutic profiles.
  • The accelerated DNA damage kinetics of these targeted complexes suggest enhanced cytotoxic potential.

Related Concept Videos

DNA Base Pairing02:27

DNA Base Pairing

Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...